Lobe Sciences Ltd. and Clearway Global LLC Enter into a Development Agreement to Manage Lobe Sciences Ltd.'s Global Regulatory and Development Strategy and its Implementation Pharmaceutical Investing
Gilead to Present Latest Data From Across Liver Disease Development Programs at the International Liver Congress 2022 Pharmaceutical Investing
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies Forum Pharmaceutical Investing
AbbVie Submits Supplemental New Drug Application to U.S. FDA for Atogepant ) to Support Label Expansion for the Preventive Treatment of Migraine Pharmaceutical Investing
Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation Pharmaceutical Investing
Merck Presents Positive Results from Phase 1/2 Study Evaluating V116, the Company's Investigational Pneumococcal Conjugate Vaccine for Adults Life Science Investing
Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Dengue Research Pharmaceutical Investing
Salix to Share New Data from XIFAXAN® Clinical Research at EASL's International Liver Congress 2022 Pharmaceutical Investing
European Medicines Agency Validates Bristol Myers Squibb's Application for CAR T Cell Therapy Breyanzi in Relapsed or Refractory Large B-cell Lymphoma After First-Line Therapy Pharmaceutical Investing
Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15 Life Science Investing
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age Life Science Investing
Allergan Aesthetics publishes 'The Future of Aesthetics' global trends report providing unrivalled insight into future of industry Pharmaceutical Investing
